Global Whole Exome Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
According to APO Research, The global Whole Exome Sequencing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen and BGI, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Whole Exome Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Whole Exome Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Whole Exome Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Whole Exome Sequencing revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Whole Exome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Whole Exome Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Whole Exome Sequencing Segment by Company
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing Segment by Type
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing Segment by Application
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Whole Exome Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Whole Exome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Exome Sequencing industry.
Chapter 3: Detailed analysis of Whole Exome Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Exome Sequencingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
According to APO Research, The global Whole Exome Sequencing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Whole Exome Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen and BGI, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Whole Exome Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Whole Exome Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Whole Exome Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Whole Exome Sequencing revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Whole Exome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Whole Exome Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Whole Exome Sequencing Segment by Company
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing Segment by Type
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing Segment by Application
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Whole Exome Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Whole Exome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Exome Sequencing industry.
Chapter 3: Detailed analysis of Whole Exome Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Exome Sequencingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
199 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Whole Exome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
- 1.2.2 Agilent HaloPlex
- 1.2.3 Agilent SureSelect
- 1.2.4 Agilent SureSelect QXT
- 1.2.5 Illumina TruSeq Exome
- 1.2.6 Roche Nimblegen SeqCap
- 1.2.7 MYcroarray MYbaits
- 1.3 Market Analysis by Application
- 1.3.1 Global Whole Exome Sequencing Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
- 1.3.2 Correlation Research of Normal Human
- 1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
- 1.3.4 The Research of Complex Diseases
- 1.3.5 Mouse Exome Sequencing
- 1.4 Global Market Growth Prospects
- 1.5 Global Whole Exome Sequencing Growth Trends by Region
- 1.5.1 Global Whole Exome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
- 1.5.2 Whole Exome Sequencing Market Size by Region (2020-2025)
- 1.5.3 Whole Exome Sequencing Market Size by Region (2026-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
- 2 Global Whole Exome Sequencing Market Dynamics
- 2.1 Whole Exome Sequencing Industry Trends
- 2.2 Whole Exome Sequencing Industry Drivers
- 2.3 Whole Exome Sequencing Industry Opportunities and Challenges
- 2.4 Whole Exome Sequencing Industry Restraints
- 3 Competitive Landscape by Company
- 3.1 Global Whole Exome Sequencing Revenue by Company (2020-2025)
- 3.2 Global Whole Exome Sequencing Players Revenue Ranking, 2023 VS 2024 VS 2025
- 3.3 Global Whole Exome Sequencing Key Company Head office and Area Served
- 3.4 Global Whole Exome Sequencing Company, Product Type & Application
- 3.5 Global Whole Exome Sequencing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Whole Exome Sequencing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Whole Exome Sequencing Players Market Share by Revenue in 2024
- 3.6.3 2024 Whole Exome Sequencing Tier 1, Tier 2, and Tier 3
- 4 Whole Exome Sequencing Market by Type
- 4.1 Global Whole Exome Sequencing Market Size by Type (2020 VS 2024 VS 2031)
- 4.2 Global Whole Exome Sequencing Market Size by Type (2020-2031)
- 4.3 Global Whole Exome Sequencing Market Size Share by Type (2020-2031)
- 5 Whole Exome Sequencing Market by Application
- 5.1 Global Whole Exome Sequencing Market Size by Application (2020 VS 2024 VS 2031)
- 5.2 Global Whole Exome Sequencing Market Size by Application (2020-2031)
- 5.3 Global Whole Exome Sequencing Market Size Share by Application (2020-2031)
- 6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Comapny Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.1.4 Illumina Whole Exome Sequencing Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 Thermo Fisher
- 6.2.1 Thermo Fisher Comapny Information
- 6.2.2 Thermo Fisher Business Overview
- 6.2.3 Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.2.4 Thermo Fisher Whole Exome Sequencing Product Portfolio
- 6.2.5 Thermo Fisher Recent Developments
- 6.3 Roche
- 6.3.1 Roche Comapny Information
- 6.3.2 Roche Business Overview
- 6.3.3 Roche Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.3.4 Roche Whole Exome Sequencing Product Portfolio
- 6.3.5 Roche Recent Developments
- 6.4 Angilent
- 6.4.1 Angilent Comapny Information
- 6.4.2 Angilent Business Overview
- 6.4.3 Angilent Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.4.4 Angilent Whole Exome Sequencing Product Portfolio
- 6.4.5 Angilent Recent Developments
- 6.5 Eurofins
- 6.5.1 Eurofins Comapny Information
- 6.5.2 Eurofins Business Overview
- 6.5.3 Eurofins Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.5.4 Eurofins Whole Exome Sequencing Product Portfolio
- 6.5.5 Eurofins Recent Developments
- 6.6 Sengenics
- 6.6.1 Sengenics Comapny Information
- 6.6.2 Sengenics Business Overview
- 6.6.3 Sengenics Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.6.4 Sengenics Whole Exome Sequencing Product Portfolio
- 6.6.5 Sengenics Recent Developments
- 6.7 Ambry
- 6.7.1 Ambry Comapny Information
- 6.7.2 Ambry Business Overview
- 6.7.3 Ambry Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.7.4 Ambry Whole Exome Sequencing Product Portfolio
- 6.7.5 Ambry Recent Developments
- 6.8 Macrogen
- 6.8.1 Macrogen Comapny Information
- 6.8.2 Macrogen Business Overview
- 6.8.3 Macrogen Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.8.4 Macrogen Whole Exome Sequencing Product Portfolio
- 6.8.5 Macrogen Recent Developments
- 6.9 BGI
- 6.9.1 BGI Comapny Information
- 6.9.2 BGI Business Overview
- 6.9.3 BGI Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.9.4 BGI Whole Exome Sequencing Product Portfolio
- 6.9.5 BGI Recent Developments
- 6.10 Novo Gene
- 6.10.1 Novo Gene Comapny Information
- 6.10.2 Novo Gene Business Overview
- 6.10.3 Novo Gene Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.10.4 Novo Gene Whole Exome Sequencing Product Portfolio
- 6.10.5 Novo Gene Recent Developments
- 7 North America
- 7.1 North America Whole Exome Sequencing Market Size (2020-2031)
- 7.2 North America Whole Exome Sequencing Market Size by Type
- 7.2.1 North America Whole Exome Sequencing Market Size by Type (2020-2025)
- 7.2.2 North America Whole Exome Sequencing Market Size by Type (2026-2031)
- 7.2.3 North America Whole Exome Sequencing Market Share by Type (2020-2031)
- 7.3 North America Whole Exome Sequencing Market Size by Application
- 7.3.1 North America Whole Exome Sequencing Market Size by Application (2020-2025)
- 7.3.2 North America Whole Exome Sequencing Market Size by Application (2026-2031)
- 7.3.3 North America Whole Exome Sequencing Market Share by Application (2020-2031)
- 7.4 North America Whole Exome Sequencing Market Size by Country
- 7.4.1 North America Whole Exome Sequencing Market Size by Country (2020 VS 2024 VS 2031)
- 7.4.2 North America Whole Exome Sequencing Market Size by Country (2020-2025)
- 7.4.3 North America Whole Exome Sequencing Market Size by Country (2026-2031)
- 7.4.4 North America Whole Exome Sequencing Market Share by Country (2020-2031)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
- 8 Europe
- 8.1 Europe Whole Exome Sequencing Market Size (2020-2031)
- 8.2 Europe Whole Exome Sequencing Market Size by Type
- 8.2.1 Europe Whole Exome Sequencing Market Size by Type (2020-2025)
- 8.2.2 Europe Whole Exome Sequencing Market Size by Type (2026-2031)
- 8.2.3 Europe Whole Exome Sequencing Market Share by Type (2020-2031)
- 8.3 Europe Whole Exome Sequencing Market Size by Application
- 8.3.1 Europe Whole Exome Sequencing Market Size by Application (2020-2025)
- 8.3.2 Europe Whole Exome Sequencing Market Size by Application (2026-2031)
- 8.3.3 Europe Whole Exome Sequencing Market Share by Application (2020-2031)
- 8.4 Europe Whole Exome Sequencing Market Size by Country
- 8.4.1 Europe Whole Exome Sequencing Market Size by Country (2020 VS 2024 VS 2031)
- 8.4.2 Europe Whole Exome Sequencing Market Size by Country (2020-2025)
- 8.4.3 Europe Whole Exome Sequencing Market Size by Country (2026-2031)
- 8.4.4 Europe Whole Exome Sequencing Market Share by Country (2020-2031)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
- 9 China
- 9.1 China Whole Exome Sequencing Market Size (2020-2031)
- 9.2 China Whole Exome Sequencing Market Size by Type
- 9.2.1 China Whole Exome Sequencing Market Size by Type (2020-2025)
- 9.2.2 China Whole Exome Sequencing Market Size by Type (2026-2031)
- 9.2.3 China Whole Exome Sequencing Market Share by Type (2020-2031)
- 9.3 China Whole Exome Sequencing Market Size by Application
- 9.3.1 China Whole Exome Sequencing Market Size by Application (2020-2025)
- 9.3.2 China Whole Exome Sequencing Market Size by Application (2026-2031)
- 9.3.3 China Whole Exome Sequencing Market Share by Application (2020-2031)
- 10 Asia (Excluding China)
- 10.1 Asia Whole Exome Sequencing Market Size (2020-2031)
- 10.2 Asia Whole Exome Sequencing Market Size by Type
- 10.2.1 Asia Whole Exome Sequencing Market Size by Type (2020-2025)
- 10.2.2 Asia Whole Exome Sequencing Market Size by Type (2026-2031)
- 10.2.3 Asia Whole Exome Sequencing Market Share by Type (2020-2031)
- 10.3 Asia Whole Exome Sequencing Market Size by Application
- 10.3.1 Asia Whole Exome Sequencing Market Size by Application (2020-2025)
- 10.3.2 Asia Whole Exome Sequencing Market Size by Application (2026-2031)
- 10.3.3 Asia Whole Exome Sequencing Market Share by Application (2020-2031)
- 10.4 Asia Whole Exome Sequencing Market Size by Country
- 10.4.1 Asia Whole Exome Sequencing Market Size by Country (2020 VS 2024 VS 2031)
- 10.4.2 Asia Whole Exome Sequencing Market Size by Country (2020-2025)
- 10.4.3 Asia Whole Exome Sequencing Market Size by Country (2026-2031)
- 10.4.4 Asia Whole Exome Sequencing Market Share by Country (2020-2031)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
- 11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Whole Exome Sequencing Market Size (2020-2031)
- 11.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type
- 11.2.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2020-2025)
- 11.2.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2026-2031)
- 11.2.3 South America, Middle East & Africa Whole Exome Sequencing Market Share by Type (2020-2031)
- 11.3 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application
- 11.3.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2020-2025)
- 11.3.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2026-2031)
- 11.3.3 South America, Middle East & Africa Whole Exome Sequencing Market Share by Application (2020-2031)
- 11.4 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country
- 11.4.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2020 VS 2024 VS 2031)
- 11.4.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2020-2025)
- 11.4.3 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2026-2031)
- 11.4.4 South America, Middle East & Africa Whole Exome Sequencing Market Share by Country (2020-2031)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
